Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia. Mould, A. W., Al-Juffali, N., von Delft, A., Brennan, P. E., & Tunbridge, E. M. CNS DRUGS, 36(1):1-16, JAN, 2022.
doi  bibtex   
@article{ WOS:000733429800001,
Author = {Mould, Arne W. and Al-Juffali, Noura and von Delft, Annette and Brennan,
   Paul E. and Tunbridge, Elizabeth M.},
Title = {Kalirin as a Novel Treatment Target for Cognitive Dysfunction in
   Schizophrenia},
Journal = {CNS DRUGS},
Year = {2022},
Volume = {36},
Number = {1},
Pages = {1-16},
Month = {JAN},
DOI = {10.1007/s40263-021-00884-z},
EarlyAccessDate = {DEC 2021},
ISSN = {1172-7047},
EISSN = {1179-1934},
ResearcherID-Numbers = {, Liz/KPB-0164-2024
   },
ORCID-Numbers = {Al-Juffali, Noura/0000-0001-9190-6729
   von Delft, Annette/0000-0002-7699-8140
   Brennan, Paul/0000-0002-8950-7646
   Tunbridge, Elizabeth/0000-0002-2966-2281
   Mould, Arne/0000-0002-2004-4348},
Unique-ID = {WOS:000733429800001},
}

Downloads: 0